Abstract:IntroductionThe success rate of in vitro fertilisation (IVF) treatment for couples with infertility remains low due to lack of a reliable tool in selecting euploid embryos for transfer. This study aims to compare the efficacy in embryo selection based on morphology alone compared with non-invasive preimplantation genetic testing for aneuploidy (niPGT-A) and morphology in infertile women undergoing IVF.Methods and analysisThis is a randomised double-blind controlled trial conducted in two tertiary assisted repr… Show more
“…One pivotal advancement lies in developing non-invasive approaches that scrutinize cell-free DNA (cfDNA) extracted from the blastocoel or embryo culture media, thus preventing the need for invasive embryo biopsies. This innovative method facilitates the evaluation of genetic status without directly impacting the embryo, mitigating the risk of damage and enhancing the overall viability of embryos [ 58 , 59 ]. Moreover, integrating sophisticated technologies such as NGS and SNP arrays into non-invasive PGT techniques has facilitated the simultaneous assessment of monogenic and chromosomal abnormalities at heightened resolution.…”
Preimplantation genetic testing (PGT) has become an integral component of assisted reproductive technology (ART), offering couples the opportunity to screen embryos for genetic abnormalities before implantation during in vitro fertilization (IVF). This comprehensive review explores the advancements and applications of PGT in IVF, covering its various types, technological developments, clinical applications, efficacy, challenges, regulatory aspects, and future directions. The evolution of PGT techniques, including next-generation sequencing (NGS) and comparative genomic hybridization (CGH), has significantly enhanced the accuracy and reliability of genetic testing in embryos. PGT holds profound implications for the future of ART by improving IVF success rates, reducing the incidence of genetic disorders, and mitigating the emotional and financial burdens associated with failed pregnancies and genetic diseases. Recommendations for clinicians, researchers, and policymakers include staying updated on the latest PGT techniques and guidelines, exploring innovative technologies, establishing clear regulatory frameworks, and fostering collaboration to maximize the potential benefits of PGT in assisted reproduction. Overall, this review provides valuable insights into the current state of PGT and its implications for the field of reproductive medicine.
“…One pivotal advancement lies in developing non-invasive approaches that scrutinize cell-free DNA (cfDNA) extracted from the blastocoel or embryo culture media, thus preventing the need for invasive embryo biopsies. This innovative method facilitates the evaluation of genetic status without directly impacting the embryo, mitigating the risk of damage and enhancing the overall viability of embryos [ 58 , 59 ]. Moreover, integrating sophisticated technologies such as NGS and SNP arrays into non-invasive PGT techniques has facilitated the simultaneous assessment of monogenic and chromosomal abnormalities at heightened resolution.…”
Preimplantation genetic testing (PGT) has become an integral component of assisted reproductive technology (ART), offering couples the opportunity to screen embryos for genetic abnormalities before implantation during in vitro fertilization (IVF). This comprehensive review explores the advancements and applications of PGT in IVF, covering its various types, technological developments, clinical applications, efficacy, challenges, regulatory aspects, and future directions. The evolution of PGT techniques, including next-generation sequencing (NGS) and comparative genomic hybridization (CGH), has significantly enhanced the accuracy and reliability of genetic testing in embryos. PGT holds profound implications for the future of ART by improving IVF success rates, reducing the incidence of genetic disorders, and mitigating the emotional and financial burdens associated with failed pregnancies and genetic diseases. Recommendations for clinicians, researchers, and policymakers include staying updated on the latest PGT techniques and guidelines, exploring innovative technologies, establishing clear regulatory frameworks, and fostering collaboration to maximize the potential benefits of PGT in assisted reproduction. Overall, this review provides valuable insights into the current state of PGT and its implications for the field of reproductive medicine.
“…Assisted reproduction techniques have significantly contributed to enabling conception for many infertile couples. However, despite advancements in ovarian stimulation, culture mediums, and laboratory conditions, the success rates for pregnancy and live births per transfer stand at approximately 35%-45% and 25%-36%, respectively [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Recurrent implantation failure (RIF) poses a profound challenge for both couples and medical professionals, signifying the absence of pregnancy despite the use of high-quality embryos and without discernible causes. Chromosomal aberrations constitute a leading cause of pregnancy failure, miscarriage, and congenital anomalies in both natural conception and pregnancies resulting from in vitro fertilization (IVF) [6].…”
This study evaluates how chromosomal factors affect assisted reproduction techniques (ART) challenges among infertile couples, impacting their chances of conception. Chromosomal abnormalities, a leading cause of pregnancy failure and miscarriages, were investigated in a four-year retrospective study involving 100 patients with a history of infertility and unsuccessful IVF treatment. Among these cases, nine (9%) displayed aberrant chromosomal patterns, including balanced translocations (5%), sex chromosome deletions (3%), and one case of a small supernumerary marker chromosome (sSMC) (1%). The results of the present study highlight the importance of integrating comprehensive cytogenetic analysis as a routine diagnostic tool for individuals dealing with infertility, particularly before assisted reproduction techniques, to avert recurrent implantation failure and to enhance their chances of success.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.